Patent · US Active

Substituted dibenzo[FG,OP]tetracenes and formulations or electronic devices containing the same

US9029425B2 · kind B2 · utility

2Cited by

1References

19Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Thomas Eberle · Landau, DE
Rémi Manouk Anémian · Seoul, KR
Sigurd Hoeger · Bonn, DE
Vanessa Bobbe · Bonn, DE
Anna Jochemich · Bonn, DE

Key dates

Filing date	Jan 18, 2012
Grant date	May 12, 2015
Priority date	—
Expiry date	Jan 18, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02E10/549
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to a compound of the formula (2) and its uses thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.